Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban during primary PCI for STEMI
ChiCTR-TRC-14004226Phase 4Completed
- Sponsor
- Tianjin Fifth Central Hospital
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in myocardial infarction (MI) (2 arms), sponsored by Tianjin Fifth Central Hospital. Primary endpoints: CD62p, PAC-1 and 3 more. Started Jul 2011; status: completed.
02
Drugs
tirofiban
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-TRC-14004226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004226.